Summary

Reconstituting lyophilized (freeze‑dried) peptides is a critical step in preparing compounds for laboratory use. When performed correctly, reconstitution preserves peptide integrity, minimizes contamination risk, and ensures accurate experimental dosing. This guide outlines the basic procedures and sterile handling techniques required for proper reconstitution.

Understanding Lyophilized Peptides

Most research peptides are supplied in a lyophilized (freeze‑dried) form. This stabilizes the compound for storage and shipping. Before use in laboratory experiments, the powder must be reconstituted with a suitable diluent—usually sterile or bacteriostatic water—to bring it into solution.

Materials Needed

• Sterile or bacteriostatic water
• Sterile mixing syringe (1–3 mL)
• Sterile needle (e.g., 21–25 gauge)
• Alcohol swabs (70% isopropyl)
• Lyophilized peptide vial
• Optional: empty sterile vial for transferring
• Gloves, lab coat, face mask

Preparation Steps

1. Clean your workspace thoroughly with 70% isopropyl alcohol and allow it to dry.
2. Lay out all required materials in an organized manner to minimize movement during reconstitution.
3. Wash hands and put on nitrile gloves. Use a face mask if available.
4. Use alcohol swabs to disinfect the tops of both the peptide vial and the diluent vial.

Reconstitution Procedure

• Draw the desired volume of sterile or bacteriostatic water into the syringe. For example, 2 mL of diluent is commonly used for a 5 mg vial, but this depends on the desired concentration.
• Insert the needle slowly through the stopper of the peptide vial. Angle the needle so the diluent runs gently down the inside wall of the vial. Avoid injecting directly onto the powder to prevent foaming or peptide damage.
• Inject the diluent slowly and steadily. Do not create excessive pressure in the vial.
• Once the diluent is fully injected, gently swirl the vial in a circular motion. Do not shake vigorously, as this can damage the peptide structure.
• Continue swirling until all powder is fully dissolved and the solution is clear.

Concentration Example (General)

As a general example:
– A 5 mg vial reconstituted with 2 mL of bacteriostatic water yields a solution with a concentration of 2.5 mg/mL.
– A 10 mg vial reconstituted with 4 mL yields the same concentration.

This example is for illustrative purposes only. Actual volumes should be determined based on the intended research protocol.

Post-Reconstitution Handling

1. Label the vial clearly with the compound name, concentration, and date of reconstitution.
2. Refrigerate the vial immediately after mixing, unless otherwise specified by the supplier.
3. Avoid repeated freeze–thaw cycles, as this can degrade the peptide.
4. If transferring to a new vial, ensure the destination vial is sterile and the transfer is performed under sterile conditions.

Key Takeaways

– Always reconstitute peptides using sterile technique to maintain sample integrity.
– Inject diluent slowly along the vial wall to minimize foaming.
– Gently swirl—never shake—when dissolving the peptide.
– Proper labeling and storage extend the usable life of the solution.

NOTICE OF COMPLIANCE

The mission of BioGenix Peptides™ is to provide researchers with the highest-quality, Ultra-Pure Series™ compounds to help unlock the full potential of this evolving field. With precision, purity, and scientific integrity at the core of our operations, BioGenix Peptides™ is dedicated to supporting responsible exploration and discovery

Products from BioGenix Peptides™ are not intended for human consumption. They are supplied exclusively for in-vitro and pre-clinical research purposes.

By purchasing or using these products, the Customer accepts full responsibility for their handling and use, and agrees to indemnify and hold BioGenix Peptides™ harmless from any claims resulting from misuse.